SlideShare a Scribd company logo
PRESENTED TO:
Prof. S.P. AGARWAL
By :
POLISHETTY
NAVALIKA
M.PHARMACY
(PHARMACEUTICS)
A10647016015
PHARMACOVIGILANCE
PHARMACOVIGILANCE
Pharmacovigilance (PV) also known as drug safety.
Pharmakon Drug
Vigilare To keep watch
•Pharmacovigilance(PV) is the pharmacological
science relating to the detection, evaluation,
understanding and prevention of adverse drug
reactions or any other drug-related problems .
•As such, pharmacovigilance heavily focuses
on adverse drug reactions, or ADRs.
PHARMACOVIGILANCE
•To role pharmacovigilance they receiving
information data from patients and health care
providers via pharmacovigilance agreements
(PVAs), as well as other sources such as the medical
literature.
•Ultimately, pharmacovigilance is concerned with
identifying the hazards associated with
pharmaceutical products and with minimizing the
risk of any harm that may come to patients.
PHARMACOVIGILANCE
Pharmacovigilance
Major Aims
• early detection of unknown safety problems
• identification of risk factors
• quantifying risks
• preventing patients from being affected
unnecessarily
Rational and Safe use of Medicines
5
Cycle for New Drug Approval
Why Pharmacovigilance?
Pre-marketing safety data
• Animal Experiments: Relevant?
• Clinical Trials: Complete?
7
Why Pharmacovigilance?
Post Marketing Topics
• Unexpected adverse reactions
• Interactions
• Risk factors
• Quality of life
• Long-term efficacy
• Cost assessment
8
Why Pharmacovigilance?
10% of people of the some countries is admitted
in hospital due to ADR events .
Adverse Drug Reactions are among the top ten
causes of mortality.
9
Work flow
GOVERNING BODIES
•The pharmaceutical industry.
•Regulatory authorities.
•WHO collaborating centre for international drug
monitoring.
•CIOMS(Council for International Organisation of
Medical Science).
WHO Programme for International Drug
Monitoring
12
WHO
HQ
WHO
Collaborating
Centre, Uppsala
National
Centres
•Policy.
•Exchange of Information.
•Technical support to
countries .
•Advisory Committee on
Safety of Medicinal Products.
ADR Reports
•Analysis
•Output
Feedback to National
Centres.
Signal documents.
Adverse event
•Any adverse change in health or side effect that occurs
while the patient is receiving the treatment.
Serious adverse event(SAE)
It is defined as any adverse event occurrence that at any
dose results.
•In death
•Is life threatening
•Requries inpatient hospitalization
•Birth defect
•Permanent damage
ADVERSE DRUG REACTION (ADR)
•An adverse drug reaction (ADR) is an injury caused
by taking a medication. ADRs may occur following a
single dose or prolonged administration of a drug or
result from the combination of two or more drugs.
•The study of ADRs is the concern of the field known
as pharmacovigilance.
ADVERSE DRUG REACTION (ADR)
REPORTING PROCEDURES
•Every country with a
developed pharmacovigilance
system has its own form.
National reporting Form
Yellow card scheme
•The Yellow Card Scheme is the UK system for
collecting information on suspected adverse
drug reactions (ADRs) to medicines.
•ADRs can be reported by anyone; this is usually
done by healthcare professionals – including
doctors, pharmacists and nurses – but patients
and carers can also make reports.
Yellow card scheme
It contains patient details , suspected drug and suspected reaction
Periodic safety update Report(PSURs)
Periodic Safety Update Reports (PSURs) is a
pharmacovigilance document intended to provide an
evaluation of the risk-benefit balance of a medicinal
product at defined time points post- authorization.
First 2 years: every 6 months.
Next 2 years: every year.
After that every 3 years.
But this (PSURs) now changes to PBRER (periodic
benefit risk evaluation report, on 21st Jul in 2012).
Pharmacovigilance program of
india (PVPI)
•Officially started on 23 November 2004 at new
Delhi.
PVPI is under control of-
1. CDSCO(Centarl Drugs Standard Control
Organization).
2. Directorate general of health services.
3. Indian pharmacopeia commission (Ghaziabad).
4. The programme is conducting by NCC(National
Coordinatinating Center)
Objectives :-
•To monitor the ADRs.
•To create awareness among health care
professionals about ADRs.
•To monitor benefits-rifts of the drug.
•Supports CDSCO.
•Communicate findings with all stake holders.
•Create a national centre.
PVPI will be administered and monitored by
the following committees.
1. Steering committee.
2. Strategic advisory committee.
Technical support by-
1. Signal review panel
2. Core training panel
3. Quality review panel
Program communications
Pharmacovigilance

More Related Content

What's hot

Basic terminologies used in pharmacovigilance.pptx
Basic terminologies used in pharmacovigilance.pptxBasic terminologies used in pharmacovigilance.pptx
Basic terminologies used in pharmacovigilance.pptx
ReshmaManeDeshmukh
 
Establishing Pharmacovigilance Centres In Hospital.pptx
Establishing Pharmacovigilance Centres In Hospital.pptxEstablishing Pharmacovigilance Centres In Hospital.pptx
Establishing Pharmacovigilance Centres In Hospital.pptx
RushikeshTidake
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
Naina Mohamed, PhD
 
Pharmacovigilance program of India (PvPI)
Pharmacovigilance program of India (PvPI)Pharmacovigilance program of India (PvPI)
Pharmacovigilance program of India (PvPI)
SnehaKhandale1
 
1.2 Importance of safety monitoring of Medicine.pptx
1.2 Importance of safety monitoring of Medicine.pptx1.2 Importance of safety monitoring of Medicine.pptx
1.2 Importance of safety monitoring of Medicine.pptx
ReshmaManeDeshmukh
 
Pharmacovigilance methods
Pharmacovigilance methodsPharmacovigilance methods
Pharmacovigilance methods
Dr. Ramesh Bhandari
 
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLS
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLSDrug Safety & Pharmacovigilance - Introduction - Katalyst HLS
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLS
Katalyst HLS
 
Aggregate Reporting_Pharmacovigilance_Katalyst HLS
Aggregate Reporting_Pharmacovigilance_Katalyst HLSAggregate Reporting_Pharmacovigilance_Katalyst HLS
Aggregate Reporting_Pharmacovigilance_Katalyst HLS
Katalyst HLS
 
Active and passive survillance
Active and passive survillanceActive and passive survillance
Active and passive survillance
Ramavath Aruna
 
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’SSEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
Raghavendra institute of pharmaceutical education and research .
 
Pharmacovigilance Planning
Pharmacovigilance PlanningPharmacovigilance Planning
Pharmacovigilance Planning
ClinosolIndia
 
MHRA Yellow Card Scheme
MHRA Yellow Card SchemeMHRA Yellow Card Scheme
MHRA Yellow Card Scheme
The QCCP
 
Pharmacovigilance ppt
Pharmacovigilance pptPharmacovigilance ppt
Pharmacovigilance ppt
Prasad Bhat
 
Pharmacovigilance signal and signal detection
Pharmacovigilance signal and signal detectionPharmacovigilance signal and signal detection
Pharmacovigilance signal and signal detection
KiranRajput38
 
Regulatory terminologies used in PV (Pharmacovigilance)
Regulatory terminologies used in PV (Pharmacovigilance)Regulatory terminologies used in PV (Pharmacovigilance)
Regulatory terminologies used in PV (Pharmacovigilance)
MubasheeraMg
 
Pharmacovigilance
Pharmacovigilance Pharmacovigilance
Pharmacovigilance
Anurag Chourasia
 
Spontaneous reporting
Spontaneous reportingSpontaneous reporting
Spontaneous reporting
ShahiBushraKhan1
 
Setting up of new pharmacovigilance centres
Setting up of new pharmacovigilance centresSetting up of new pharmacovigilance centres
Setting up of new pharmacovigilance centres
Priti Gupta
 
Pharmacovigilance programme of india
Pharmacovigilance programme of indiaPharmacovigilance programme of india
Pharmacovigilance programme of india
chandan kumar
 
Signal detection and management
Signal detection and managementSignal detection and management
Signal detection and management
sekharbabu41
 

What's hot (20)

Basic terminologies used in pharmacovigilance.pptx
Basic terminologies used in pharmacovigilance.pptxBasic terminologies used in pharmacovigilance.pptx
Basic terminologies used in pharmacovigilance.pptx
 
Establishing Pharmacovigilance Centres In Hospital.pptx
Establishing Pharmacovigilance Centres In Hospital.pptxEstablishing Pharmacovigilance Centres In Hospital.pptx
Establishing Pharmacovigilance Centres In Hospital.pptx
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Pharmacovigilance program of India (PvPI)
Pharmacovigilance program of India (PvPI)Pharmacovigilance program of India (PvPI)
Pharmacovigilance program of India (PvPI)
 
1.2 Importance of safety monitoring of Medicine.pptx
1.2 Importance of safety monitoring of Medicine.pptx1.2 Importance of safety monitoring of Medicine.pptx
1.2 Importance of safety monitoring of Medicine.pptx
 
Pharmacovigilance methods
Pharmacovigilance methodsPharmacovigilance methods
Pharmacovigilance methods
 
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLS
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLSDrug Safety & Pharmacovigilance - Introduction - Katalyst HLS
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLS
 
Aggregate Reporting_Pharmacovigilance_Katalyst HLS
Aggregate Reporting_Pharmacovigilance_Katalyst HLSAggregate Reporting_Pharmacovigilance_Katalyst HLS
Aggregate Reporting_Pharmacovigilance_Katalyst HLS
 
Active and passive survillance
Active and passive survillanceActive and passive survillance
Active and passive survillance
 
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’SSEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
 
Pharmacovigilance Planning
Pharmacovigilance PlanningPharmacovigilance Planning
Pharmacovigilance Planning
 
MHRA Yellow Card Scheme
MHRA Yellow Card SchemeMHRA Yellow Card Scheme
MHRA Yellow Card Scheme
 
Pharmacovigilance ppt
Pharmacovigilance pptPharmacovigilance ppt
Pharmacovigilance ppt
 
Pharmacovigilance signal and signal detection
Pharmacovigilance signal and signal detectionPharmacovigilance signal and signal detection
Pharmacovigilance signal and signal detection
 
Regulatory terminologies used in PV (Pharmacovigilance)
Regulatory terminologies used in PV (Pharmacovigilance)Regulatory terminologies used in PV (Pharmacovigilance)
Regulatory terminologies used in PV (Pharmacovigilance)
 
Pharmacovigilance
Pharmacovigilance Pharmacovigilance
Pharmacovigilance
 
Spontaneous reporting
Spontaneous reportingSpontaneous reporting
Spontaneous reporting
 
Setting up of new pharmacovigilance centres
Setting up of new pharmacovigilance centresSetting up of new pharmacovigilance centres
Setting up of new pharmacovigilance centres
 
Pharmacovigilance programme of india
Pharmacovigilance programme of indiaPharmacovigilance programme of india
Pharmacovigilance programme of india
 
Signal detection and management
Signal detection and managementSignal detection and management
Signal detection and management
 

Similar to Pharmacovigilance

Signifcance of pharmacovigilance & risk management plan
Signifcance of pharmacovigilance & risk management planSignifcance of pharmacovigilance & risk management plan
Signifcance of pharmacovigilance & risk management plan
Ansuman Parida
 
pharmacovigilance pdf (1)
pharmacovigilance pdf (1)pharmacovigilance pdf (1)
pharmacovigilance pdf (1)Prasad Bhat
 
Pharmacovigilance pdf (1)
Pharmacovigilance pdf (1)Pharmacovigilance pdf (1)
Pharmacovigilance pdf (1)
Prasad Bhat
 
Pharmacovigilance by bishnu koirala
Pharmacovigilance by bishnu koiralaPharmacovigilance by bishnu koirala
Pharmacovigilance by bishnu koirala
Bishnu Koirala
 
Pharmacovigilance of Natural Drugs- Durgashree Diwakr
Pharmacovigilance of Natural Drugs- Durgashree  DiwakrPharmacovigilance of Natural Drugs- Durgashree  Diwakr
Pharmacovigilance of Natural Drugs- Durgashree Diwakr
Durgashree Diwakar
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
Hesham Al-Khateeb
 
Pharmacovigilance (PV)
Pharmacovigilance (PV)Pharmacovigilance (PV)
Pharmacovigilance (PV)
SANDEEP MEWADA
 
1591115199267_Pharmacovigilance.pptx
1591115199267_Pharmacovigilance.pptx1591115199267_Pharmacovigilance.pptx
1591115199267_Pharmacovigilance.pptx
DrAniqaSundas
 
PHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
PHARMACOVIGILANCE - A Worldwide masterkey for Drug MonitoringPHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
PHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
Venugopal N
 
Pharmacovigilanve And Its Importance
Pharmacovigilanve And Its ImportancePharmacovigilanve And Its Importance
Pharmacovigilanve And Its Importance
shubham sinha
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
Vignesh K
 
Methods and Tools for ADR Reporting.pptx
Methods and Tools for ADR Reporting.pptxMethods and Tools for ADR Reporting.pptx
Methods and Tools for ADR Reporting.pptx
PankajKadyan5
 
Pharmacovigilance and adr
Pharmacovigilance and adrPharmacovigilance and adr
Pharmacovigilance and adr
Nilesh Siddhawar
 
Adr reporting ppt
Adr reporting pptAdr reporting ppt
Adr reporting ppt
RimaSingh14
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
NEHA GUPTA
 
An overview -Pharmacovigilance by Pougang Golmei,m.pharm,RIPANS,Mizoram
An overview -Pharmacovigilance by Pougang Golmei,m.pharm,RIPANS,MizoramAn overview -Pharmacovigilance by Pougang Golmei,m.pharm,RIPANS,Mizoram
An overview -Pharmacovigilance by Pougang Golmei,m.pharm,RIPANS,Mizoram
pougang golmei
 
Understanding pharmacovigilance
Understanding pharmacovigilanceUnderstanding pharmacovigilance
Understanding pharmacovigilance
finenessinstitute
 
pharmacovigilance
pharmacovigilance  pharmacovigilance
pharmacovigilance
konatham teja kumar reddy
 
Safety Reporting and Pharmacovigilance.pptx
Safety Reporting and Pharmacovigilance.pptxSafety Reporting and Pharmacovigilance.pptx
Safety Reporting and Pharmacovigilance.pptx
abhishektengli2
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
arun chand roby
 

Similar to Pharmacovigilance (20)

Signifcance of pharmacovigilance & risk management plan
Signifcance of pharmacovigilance & risk management planSignifcance of pharmacovigilance & risk management plan
Signifcance of pharmacovigilance & risk management plan
 
pharmacovigilance pdf (1)
pharmacovigilance pdf (1)pharmacovigilance pdf (1)
pharmacovigilance pdf (1)
 
Pharmacovigilance pdf (1)
Pharmacovigilance pdf (1)Pharmacovigilance pdf (1)
Pharmacovigilance pdf (1)
 
Pharmacovigilance by bishnu koirala
Pharmacovigilance by bishnu koiralaPharmacovigilance by bishnu koirala
Pharmacovigilance by bishnu koirala
 
Pharmacovigilance of Natural Drugs- Durgashree Diwakr
Pharmacovigilance of Natural Drugs- Durgashree  DiwakrPharmacovigilance of Natural Drugs- Durgashree  Diwakr
Pharmacovigilance of Natural Drugs- Durgashree Diwakr
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Pharmacovigilance (PV)
Pharmacovigilance (PV)Pharmacovigilance (PV)
Pharmacovigilance (PV)
 
1591115199267_Pharmacovigilance.pptx
1591115199267_Pharmacovigilance.pptx1591115199267_Pharmacovigilance.pptx
1591115199267_Pharmacovigilance.pptx
 
PHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
PHARMACOVIGILANCE - A Worldwide masterkey for Drug MonitoringPHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
PHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
 
Pharmacovigilanve And Its Importance
Pharmacovigilanve And Its ImportancePharmacovigilanve And Its Importance
Pharmacovigilanve And Its Importance
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Methods and Tools for ADR Reporting.pptx
Methods and Tools for ADR Reporting.pptxMethods and Tools for ADR Reporting.pptx
Methods and Tools for ADR Reporting.pptx
 
Pharmacovigilance and adr
Pharmacovigilance and adrPharmacovigilance and adr
Pharmacovigilance and adr
 
Adr reporting ppt
Adr reporting pptAdr reporting ppt
Adr reporting ppt
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
 
An overview -Pharmacovigilance by Pougang Golmei,m.pharm,RIPANS,Mizoram
An overview -Pharmacovigilance by Pougang Golmei,m.pharm,RIPANS,MizoramAn overview -Pharmacovigilance by Pougang Golmei,m.pharm,RIPANS,Mizoram
An overview -Pharmacovigilance by Pougang Golmei,m.pharm,RIPANS,Mizoram
 
Understanding pharmacovigilance
Understanding pharmacovigilanceUnderstanding pharmacovigilance
Understanding pharmacovigilance
 
pharmacovigilance
pharmacovigilance  pharmacovigilance
pharmacovigilance
 
Safety Reporting and Pharmacovigilance.pptx
Safety Reporting and Pharmacovigilance.pptxSafety Reporting and Pharmacovigilance.pptx
Safety Reporting and Pharmacovigilance.pptx
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 

Recently uploaded

Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 

Recently uploaded (20)

Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 

Pharmacovigilance

  • 1. PRESENTED TO: Prof. S.P. AGARWAL By : POLISHETTY NAVALIKA M.PHARMACY (PHARMACEUTICS) A10647016015 PHARMACOVIGILANCE
  • 2. PHARMACOVIGILANCE Pharmacovigilance (PV) also known as drug safety. Pharmakon Drug Vigilare To keep watch
  • 3. •Pharmacovigilance(PV) is the pharmacological science relating to the detection, evaluation, understanding and prevention of adverse drug reactions or any other drug-related problems . •As such, pharmacovigilance heavily focuses on adverse drug reactions, or ADRs. PHARMACOVIGILANCE
  • 4. •To role pharmacovigilance they receiving information data from patients and health care providers via pharmacovigilance agreements (PVAs), as well as other sources such as the medical literature. •Ultimately, pharmacovigilance is concerned with identifying the hazards associated with pharmaceutical products and with minimizing the risk of any harm that may come to patients. PHARMACOVIGILANCE
  • 5. Pharmacovigilance Major Aims • early detection of unknown safety problems • identification of risk factors • quantifying risks • preventing patients from being affected unnecessarily Rational and Safe use of Medicines 5
  • 6. Cycle for New Drug Approval
  • 7. Why Pharmacovigilance? Pre-marketing safety data • Animal Experiments: Relevant? • Clinical Trials: Complete? 7
  • 8. Why Pharmacovigilance? Post Marketing Topics • Unexpected adverse reactions • Interactions • Risk factors • Quality of life • Long-term efficacy • Cost assessment 8
  • 9. Why Pharmacovigilance? 10% of people of the some countries is admitted in hospital due to ADR events . Adverse Drug Reactions are among the top ten causes of mortality. 9
  • 11. GOVERNING BODIES •The pharmaceutical industry. •Regulatory authorities. •WHO collaborating centre for international drug monitoring. •CIOMS(Council for International Organisation of Medical Science).
  • 12. WHO Programme for International Drug Monitoring 12 WHO HQ WHO Collaborating Centre, Uppsala National Centres •Policy. •Exchange of Information. •Technical support to countries . •Advisory Committee on Safety of Medicinal Products. ADR Reports •Analysis •Output Feedback to National Centres. Signal documents.
  • 13. Adverse event •Any adverse change in health or side effect that occurs while the patient is receiving the treatment. Serious adverse event(SAE) It is defined as any adverse event occurrence that at any dose results. •In death •Is life threatening •Requries inpatient hospitalization •Birth defect •Permanent damage
  • 14. ADVERSE DRUG REACTION (ADR) •An adverse drug reaction (ADR) is an injury caused by taking a medication. ADRs may occur following a single dose or prolonged administration of a drug or result from the combination of two or more drugs. •The study of ADRs is the concern of the field known as pharmacovigilance.
  • 15. ADVERSE DRUG REACTION (ADR) REPORTING PROCEDURES •Every country with a developed pharmacovigilance system has its own form. National reporting Form
  • 16. Yellow card scheme •The Yellow Card Scheme is the UK system for collecting information on suspected adverse drug reactions (ADRs) to medicines. •ADRs can be reported by anyone; this is usually done by healthcare professionals – including doctors, pharmacists and nurses – but patients and carers can also make reports.
  • 17. Yellow card scheme It contains patient details , suspected drug and suspected reaction
  • 18. Periodic safety update Report(PSURs) Periodic Safety Update Reports (PSURs) is a pharmacovigilance document intended to provide an evaluation of the risk-benefit balance of a medicinal product at defined time points post- authorization. First 2 years: every 6 months. Next 2 years: every year. After that every 3 years. But this (PSURs) now changes to PBRER (periodic benefit risk evaluation report, on 21st Jul in 2012).
  • 19. Pharmacovigilance program of india (PVPI) •Officially started on 23 November 2004 at new Delhi. PVPI is under control of- 1. CDSCO(Centarl Drugs Standard Control Organization). 2. Directorate general of health services. 3. Indian pharmacopeia commission (Ghaziabad). 4. The programme is conducting by NCC(National Coordinatinating Center)
  • 20. Objectives :- •To monitor the ADRs. •To create awareness among health care professionals about ADRs. •To monitor benefits-rifts of the drug. •Supports CDSCO. •Communicate findings with all stake holders. •Create a national centre.
  • 21. PVPI will be administered and monitored by the following committees. 1. Steering committee. 2. Strategic advisory committee. Technical support by- 1. Signal review panel 2. Core training panel 3. Quality review panel